1. Home
  2. AVTX vs VABK Comparison

AVTX vs VABK Comparison

Compare AVTX & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • VABK
  • Stock Information
  • Founded
  • AVTX 2011
  • VABK 1998
  • Country
  • AVTX United States
  • VABK United States
  • Employees
  • AVTX N/A
  • VABK N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • VABK Major Banks
  • Sector
  • AVTX Health Care
  • VABK Finance
  • Exchange
  • AVTX Nasdaq
  • VABK Nasdaq
  • Market Cap
  • AVTX 248.3M
  • VABK 203.8M
  • IPO Year
  • AVTX 2015
  • VABK N/A
  • Fundamental
  • Price
  • AVTX $15.14
  • VABK $40.63
  • Analyst Decision
  • AVTX Strong Buy
  • VABK
  • Analyst Count
  • AVTX 9
  • VABK 0
  • Target Price
  • AVTX $30.14
  • VABK N/A
  • AVG Volume (30 Days)
  • AVTX 412.1K
  • VABK 11.0K
  • Earning Date
  • AVTX 11-06-2025
  • VABK 10-23-2025
  • Dividend Yield
  • AVTX N/A
  • VABK 3.60%
  • EPS Growth
  • AVTX N/A
  • VABK 14.21
  • EPS
  • AVTX N/A
  • VABK 3.30
  • Revenue
  • AVTX $192,000.00
  • VABK $56,512,000.00
  • Revenue This Year
  • AVTX N/A
  • VABK N/A
  • Revenue Next Year
  • AVTX N/A
  • VABK N/A
  • P/E Ratio
  • AVTX N/A
  • VABK $12.13
  • Revenue Growth
  • AVTX N/A
  • VABK 10.39
  • 52 Week Low
  • AVTX $3.39
  • VABK $33.66
  • 52 Week High
  • AVTX $19.41
  • VABK $44.57
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 48.12
  • VABK 52.04
  • Support Level
  • AVTX $14.16
  • VABK $38.78
  • Resistance Level
  • AVTX $16.03
  • VABK $41.19
  • Average True Range (ATR)
  • AVTX 1.27
  • VABK 0.93
  • MACD
  • AVTX -0.42
  • VABK 0.04
  • Stochastic Oscillator
  • AVTX 23.40
  • VABK 51.20

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

Share on Social Networks: